Perspective Therapeutics, Inc. 2026 Annual Meeting of Stockholders Summary

On May 27, 2026, Perspective Therapeutics, Inc. held its 2026 Annual Meeting of Stockholders. A quorum was established with 85.85% of outstanding shares represented. Stockholders elected six directors: Lori A. Woods, Heidi Henson, Maya Martinez-Davis, Frank Morich, M.D., Ph.D., Johan (Thijs) Spoor, and Robert Froman Williamson, III, all to serve until the 2027 Annual Meeting. The appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified. Additionally, stockholders voted, on a non-binding advisory basis, to hold future advisory votes on executive compensation annually. The Board of Directors will adhere to this annual frequency until otherwise determined.